EVerZom Overview
- Founded
-
2019

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$950K
- Investors
-
8
EVerZom General Information
Description
Operator of a nanomedicine biotech company designed to create extracellular vesicles. The company's extracellular vesicles have protective and reparative properties representing an important therapeutic tool, enabling healthcare professionals to use them to overcome the failure of an organ, restoring its function and homeostasis.
Contact Information
Website
www.everzom.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 45 Rue des Saints-Pères
- 75006 Paris
- France
EVerZom Timeline
EVerZom Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 03-Dec-2020 | $950K | 00000 | Completed | Generating Revenue | |
2. Grant | 13-Dec-2019 | 000.00 | Completed | Startup | ||
1. Accelerator/Incubator | 01-Jul-2019 | Completed | Startup |
EVerZom Executive Team (6)
EVerZom Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Amanda Brun Ph.D | Self | Co-Founder, CSO & Scientific Board Member | 000 0000 |
Claire Wilhelm | EVerZom | Co-Founder & Scientific Board Member | 000 0000 |
EVerZom Signals
EVerZom Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | |
d'lle de France | Other | Minority | 000 0000 | 000000 0 | |
Erganeo | Venture Capital | Minority | 000 0000 | 000000 0 | |
Innov'Up Leader Pia | Corporation | Minority | 000 0000 | 000000 0 | |
La French Tech | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |